Drug Profile
Malaria vaccine MSP1/QS-21 - Antigenics
Alternative Names: MSP1/QS-21Latest Information Update: 25 Sep 2006
Price :
$50
*
At a glance
- Originator Antigenics
- Developer Antigenics; University of Hawaii
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Falciparum malaria
Most Recent Events
- 24 Sep 2006 Discontinued - Preclinical for Falciparum malaria in USA (unspecified route)
- 12 Dec 2003 No development reported - Preclinical for Falciparum malaria in USA (unspecified route)
- 27 Aug 2001 Aquila Biopharmaceuticals has been integrated into Antigenics